cp wire

CP Wire Articles

Amicus Announces Positive Results for AT-GAA in Pompe Disease
  • Muscle funtion improved in 17 of 19 patients at month 12
  • Treatment with AT-GAA resulted in persistent and durable reductions in key biomarkers of muscle damage across all patient... read more
Fri, 10/5/18 - 09:46 am
EMA Accepts Bluebird Bio's Marketing Authorization Application for Gene Therapy for Rare Blood Disorder
  • LentiGlobin has Orphan Drug status in Europe and the US
  • It has also been granted an accelerated assessment in Europe and Breakthrough Therapy designation in the US
  • ... read more
Fri, 10/5/18 - 09:18 am
Microbiome Report for Week Ending 9/29/18

Second Genome Appoints Karim Dabbagh, Ph.D., as Chief... read more

Thu, 10/4/18 - 02:59 pm
Vaxart Stock Soars on Oral Flu Vaccine Results

Vaxart Stock is up over 165% after after the biotechnology company announced results from a phase 2 trial that its oral flu vaccine performed better than Sanofi's Fluzone.

"These latest... read more

Thu, 10/4/18 - 09:57 am
Esanex Has Successful Ph II Meeting with FDA Meeting for SNX-5422 Upcoming Trial in Neuroendocrine Tumors
  • SNX-5422 has been granted Orphan Drug Status for neuroendocrine tumors by the FDA
  • SNX-5422 is an orally active Hsp90 inhibitor that has provided durable clinical responses in open... read more
Thu, 10/4/18 - 09:28 am

Pages